Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 7.4B | 7.0B | 7.9B | 6.4B |
Cost of revenue | 3.7B | 3.8B | 4.3B | 4.1B |
Gross profit | 3.8B | 3.2B | 3.6B | 2.3B |
Operating expense | ||||
Research & development | 56.0M | 60.2M | 67.2M | 65.8M |
Selling general and admin | 133.0M | 154.0M | 179.2M | 158.2M |
Other operating expenses | 201.6M | 198.8M | 120.4M | 288.4M |
Operating income | 3.4B | 2.8B | 3.2B | 1.8B |
Non operating interest income | ||||
Income | 75.6M | 57.4M | 53.2M | 51.8M |
Expense | 91.0M | 110.6M | 130.2M | 120.4M |
Other income expense | 996.9M | 690.3M | -281.4M | -266.0M |
Pretax income | 4.4B | 3.5B | 2.9B | 1.5B |
Tax provision | 1.5B | 905.9M | 982.9M | 341.6M |
Net income | 2.9B | 2.7B | 2.0B | 1.3B |
Basic EPS | 1.9 | 1.7 | 1.2 | 0.8 |
Diluted EPS | 1.9 | 1.7 | 1.2 | 0.8 |
Basic average shares | 1.6B | 1.6B | 1.6B | 1.6B |
Diluted average shares | 1.6B | 1.6B | 1.6B | 1.6B |
EBITDA | 4.3B | 3.7B | 4.2B | 2.7B |
Net income from continuing op. | 2.9B | 2.7B | 2.0B | 1.3B |
Minority interests | -19.6M | -15.4M | -25.2M | -2.8M |
Preferred stock dividends | — | — | — | — |